Veradermics, Incorporated(MANE:US)
Market Cap$4.547B
Key Metrics
Price$108.82
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$168.41M
Total Assets$397.36M
Net Assets$390.64M
Total Debt$0
Key Metrics
Price$108.82
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$168.41M
Total Assets$397.36M
Net Assets$390.64M
Total Debt$0
Financials

| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
| $29.55M | $29.71M | $22.75M | $12.88M | $5.97M | |
| Research and Development | $18.61M | $20.93M | $18.19M | $11.45M | $4.95M |
| Selling, General, and Administrative | $10.95M | $8.94M | $4.82M | $1.47M | $1.02M |
| Other Operating Expenses | - | -$149K | -$258K | -$33K | - |
Operating Income | -$29.55M | -$29.71M | -$22.75M | -$12.88M | -$5.58M |
| $6.05M | $2.48M | $906K | $482K | -$83K | |
| Non-Operating Interest Income | $4.84M | $2.48M | $906K | $482K | $209K |
| Non-Operating Interest Expense | - | - | $0 | - | $292K |
| Other Income/Expense | $1.21M | - | - | - | - |
Income Before Tax | -$23.5M | -$27.23M | -$21.85M | -$12.4M | -$5.66M |
Income Tax | $0 | $0 | $0 | $0 | $0 |
Net Income | -$23.5M | -$27.23M | -$21.85M | -$12.4M | -$5.66M |
Minority Interests | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - |
Net Income to Common | -$23.5M | -$27.23M | -$21.85M | -$12.4M | -$5.66M |
Shares Outstanding (Basic) | 40.44M | 22.7M | 35.08M | 19.91M | - |
Shares Outstanding (Diluted) | 40.44M | 22.7M | 35.08M | 19.91M | - |
EPS (Basic) | -$0.58 | -$1.32 | -$0.62 | -$0.73 | - |
EPS (Diluted) | -$0.58 | -$1.32 | -$0.62 | -$0.73 | - |
EBIT | -$29.55M | -$29.71M | -$21.85M | -$12.88M | -$5.37M |
EBITDA | -$29.55M | -$29.71M | -$21.85M | -$12.88M | -$5.37M |
